These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29992388)

  • 1. Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Cheung HMC; Karanicolas PJ; Coburn N; Seth V; Law C; Milot L
    Eur Radiol; 2019 Feb; 29(2):1032-1038. PubMed ID: 29992388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L
    Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L
    Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor enhancement of colorectal liver metastases on preoperative gadobutrol-enhanced MRI at 5 minutes post-contrast injection is associated with overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Quant Imaging Med Surg; 2019 Feb; 9(2):312-317. PubMed ID: 30976555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.
    Zhang L; Yu X; Huo L; Lu L; Pan X; Jia N; Fan X; Morana G; Grazioli L; Schneider G
    Eur Radiol; 2019 Oct; 29(10):5205-5216. PubMed ID: 30915560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.
    Kim B; Byun JH; Kim HJ; Won HJ; Kim SY; Shin YM; Kim PN
    Eur Radiol; 2016 Jan; 26(1):191-8. PubMed ID: 25933742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
    van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
    Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging.
    Okada M; Imai Y; Kim T; Kogita S; Takamura M; Kumano S; Onishi H; Hori M; Fukuda K; Hayashi N; Wakasa K; Sakamoto M; Murakami T
    J Magn Reson Imaging; 2010 Oct; 32(4):903-13. PubMed ID: 20882621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI with gadoxetate disodium for colorectal liver metastasis: is it the new "imaging modality of choice"?
    Patel S; Cheek S; Osman H; Jeyarajah DR
    J Gastrointest Surg; 2014 Dec; 18(12):2130-5. PubMed ID: 25319036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
    Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
    Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement.
    Hong HS; Byun JH; Won HJ; Kim KW; Lee SS; Lee MG; Yun SC
    Clin Radiol; 2010 Sep; 65(9):701-7. PubMed ID: 20696297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement.
    Matoori S; Froehlich JM; Breitenstein S; Pozdniakova V; Reischauer C; Kolokythas O; Koh DM; Gutzeit A
    Eur Radiol; 2019 Nov; 29(11):5813-5822. PubMed ID: 31020338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.